Notice of Annual General Meeting in Vistin Pharma ASA - Börskollen
Börskollen - Aktier, fonder och ekonominyheter

Börskollen

För dig med koll på börsen

Pressmeddelande

Notice of Annual General Meeting in Vistin Pharma ASA

Oslo, Norway, 28 April 2023

Vistin Pharma ASA (OSE: VISTIN), please find attached the call for the Annual General Meeting in Vistin Pharma, to be held on 22 May at 13:00 CEST.

A physical Annual General Meeting will not be held. Instead, shareholders should authorize the Chairman of the Board. It is possible to give proxy with and without voting instructions. By using a proxy with voting instructions, the shareholders will vote on the specific issues without personal attendance. For further information on the use of proxy, see general information at the bottom of the notice and enclosed proxy forms.

The recommendation from the Election Committee is available on the Company's website. The formal call will be sent to all shareholders registered in the Norwegian Central Security Depository (VPS) and are also attached to this announcement.

For further information, please contact:

Alexander Karlsen
CFO
+47 97 05 36 21
[email protected]

This information is subject to the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.

 

 

 

 

 

Attachments


Bifogade filer

Proposal Election committee Vistin ASA for AGM 2023 signerthttps://ml-eu.globenewswire.com/Resource/Download/7d1e623a-e2e6-4fb2-8388-e2d339749db7
Call for annual general meeting in Vistin Pharma ASA 22 May 2023https://ml-eu.globenewswire.com/Resource/Download/8656820e-a557-414a-bb78-a26cbcfff3f1
Remuration report for salary and other remuration for executive management and board members_Vistin Pharma ASAhttps://ml-eu.globenewswire.com/Resource/Download/24e59573-330a-4522-9322-22be0cd2fd97
Remuneration policy for salary and other remuration for executive management and board members_Vistin Pharma ASAhttps://ml-eu.globenewswire.com/Resource/Download/45a44bc0-5573-4e39-8e0c-1af5855f03a3

Nyheter om Vistin Pharma

Läses av andra just nu

Om aktien Vistin Pharma

Senaste nytt